How Does The Future Look For Retrophin Inc (NASDAQ:RTRX) and Zendesk Inc (NYSE:ZEN)?
New York, NY – GDP INSIDER – 03/20/2015.
This article discusses two companies: Retrophin Inc (NASDAQ:RTRX) and Zendesk Inc (NYSE:ZEN)
Retrophin Inc (NASDAQ:RTRX) surged following the announcement of its public offering pricing. The company announced it priced 6,840,000 shares of common stock at $19 per share. This should net the company $130 million in gross revenue to fund its research and development efforts. The underwriters also have the option to buy another 1,026,000 shares within 30-days. The news drove the stock up 9.92% or $2 to finish the day at $22.17 on heavy trading of 6.00 million shares, far exceeding its three month average trading volume of 0.419 million.
The New York-based drug maker, which specializes in the development and commercialization of therapies for the treatment of catastrophic diseases, has been outperforming the S&P 500 with the stock up 96.37% year to date, compared to the index which has only gained 1.47% since the beginning of this year. While the MFI of 89 is not concerning, the RSI of 84.63 is on the verge of pushing into more concerning territory. That said, the stock could move higher, and these technical are not yet indicating that a correction is on the horizon.
Is Retrophin Inc Worth Investing In? Learn More About Company’s Trajectory With Our Free RTRX Analysis.
Zendesk Inc (NYSE:ZEN) continued to climb yesterday with the stock closing up 0.47% or eleven cents to finish the day at $23.41 on higher than average trading volume of 4.80 million, compared to its three month average trading volume of 0.416 million, after it announced a public follow-on offering of 8.53 million shares of common stock at $22.75 per share. The underwriters also have the option to buy another 1.279 million shares within 30-days. The stock, which traded within a range of $22.75 to $23.91 during yesterday’s trading, currently situated 111.66% above its one year low of $11.96 and 16.99% below its one year high of $28.20.
Zendesk Inc has been doing well over the last 10 months, gaining 74.31% and outperforming the S&P 500 index, which is only up 11.61% for the same period. The RSI of 49.59 indicates the stock is not overvalued at the current levels, the MFI of 64.73 shows that money is flowing in the right direction and still has room to improve. With quarterly revenue growth of 71.10% year on year and consensus target estimate of $30.20, the US-based software development company is a potential investment if you buy at the right time.
Why Should You Consider Investing In Zendesk Inc Now? Click Here To See Why You Should Own ZEN In Your Portfolio.
UltimateStockAlerts.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.
UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
Disclosure: UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.